Frederic H Moll, Board Member at ShockWave Medical (NASDAQ:SWAV), executed a substantial insider sell on February 23, according to an SEC filing.
What Happened: Moll's recent move involves selling 60,000 shares of ShockWave Medical. This information is documented in a Form 4 filing with the U.S. Securities and Exchange Commission on Friday. The total value is $15,443,412.
Tracking the Friday's morning session, ShockWave Medical shares are trading at $270.53, showing a down of 0.0%.
All You Need to Know About ShockWave Medical
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.
Financial Milestones: ShockWave Medical's Journey
Revenue Growth: Over the 3 months period, ShockWave Medical showcased positive performance, achieving a revenue growth rate of 9.12% as of 31 December, 2023. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average ...